VYNE Therapeutics Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
10/10
|
2.79 | 48.77 | -94.28% | 0.5199 | +436.69% |
| P/S |
|
62.99 | 33.76 | 86.61% |
|
|
| P/BV |
|
0.301 | 4.82 | -93.76% |
|
|
| P/FCF |
|
-0.6156 | 61 | -101.01% |
|
|
| Ev/Ebitda |
|
0.1282 | -22.15 | -100.58% |
|
|
| Ev/S |
|
-8.84 | 22.56 | -139.2% |
|
|
| Ev/FCF |
|
0.148 | 68.78 | -99.78% |
|
|
| E/P |
|
-1.82 | 0.0178 | -10339.86% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-6900.47 | 4.98 | -138748.91% | -3885.48 | +77.6% |
| ROE |
|
-32.06 | 9.61 | -433.6% |
|
|
| ROA |
|
-29.13 | 0.3443 | -8560.56% |
|
|
| ROIC |
|
-111.75 | 7.63 | -1563.78% |
|
|
| ROS |
|
-6710.38 | -25.17 | 26560.11% |
|
|
| ROCE |
|
-109.17 | 15.35 | -811.22% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0073 | -3.68 | -99.8% | -0.0075 | -1.87% |
| Nеt Debt/Ebitda |
|
1.04 | -3.44 | -130.29% |
|
|
| Debt/Ratio |
|
0.0022 | 0.1985 | -98.9% |
|
|
| Debt/Equity |
|
0.0056 | 1.66 | -99.66% |
|
|
| Debt/Net Income |
|
-0.0075 | 10.32 | -100.07% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5442 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2237 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9889 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4952 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5442 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-76.44 | -56.89 | 34.36% | ||
| Growth impulse Ebitda in 5 years |
|
-61.6 | -54.68 | 12.66% | ||
| Growth impulse Net Income in 5 years |
|
-59.64 | -58.33 | 2.25% | ||
| Growth impulse FCF in 5 years |
|
-61.07 | -49.48 | 23.42% | ||
| Growth impulse EPS in 5 years |
|
-98.7 | -32.41 | 204.54% |
IP Score
3.2/10
